STERIS Announces Financial Results for Fiscal 2022 Fourth Quarter and Full Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
STERIS (STE) PT Lowered to $248 at Needham & Company
May 12, 2022 12:46 PM EDTNeedham & Company analyst Mike Matson lowered the price target on STERIS (NYSE: STE) to $248.00 (from $263.00) while maintaining a Buy rating following earnings.
The analyst commented, "STE's F4Q22 revenue and EPS beat consensus. Organic revenue growth improved from the prior quarter overall and in all... More
Steris (STE) Tops Q4 EPS by 2c
May 11, 2022 4:34 PM EDTSteris (NYSE: STE) reported Q4 EPS of $2.04, $0.02 better than the analyst estimate of $2.02. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.19 billion.
GUIDANCE:
Steris sees FY2023 EPS of $8.55-$8.75, versus the consensus of $7.91.
For earnings history and earnings-related data on Steris (STE) click here.
... More